HealthNotableSingle-source
4.9
EU pharma R&D squeezed by funding gaps, slow approvals, US MFN rules
Die PresseLO·EU · US·2 days ago
Costa Rica's Ministry of Health issued an update on drug registration procedures, potentially easing market entry for pharmaceutical companies. The change is regulatory in nature, with details on scope and impact still emerging. This matters for pharma firms assessing Latin American market access.